Skip to main content

DBV Technologies S.A. (DBVT)

NASDAQ: DBVT · IEX Real-Time Price · USD
5.11 -0.02 (-0.39%)
Sep 17, 2021 4:00 PM EDT - Market closed
Market Cap570.16M
Revenue (ttm)4.40M
Net Income (ttm)n/a
Shares Out109.93M
EPS (ttm)-1.19
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume51,793
Open5.12
Previous Close5.13
Day's Range5.06 - 5.13
52-Week Range1.35 - 7.38
Beta2.23
AnalystsBuy
Price Target10.99 (+115.1%)
Est. Earnings Daten/a

About DBVT

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults. The company is also developing Viaskin Milk that is in Phase I/II clinical trial for the treatment of Immunoglobulin E (IgE) mediated cow's milk protein allergy (CMPA) and milk-induced eosi...

IndustryBiotechnology
Founded2002
CEODaniel Tasse
Employees97
Stock ExchangeNASDAQ
Ticker SymbolDBVT
Full Company Profile

Financial Performance

In 2020, DBVT's revenue was 11.28 million, a decrease of -23.33% compared to the previous year's 14.71 million. Losses were -159.56 million, -7.24% less than in 2019.

Financial numbers in millions EURFinancial Statements

Analyst Forecast

According to 3 analysts, the average rating for DBVT stock is "Buy." The 12-month stock price forecast is 10.99, which is an increase of 115.09% from the latest price.

Price Target
$10.99
(115.09% upside)
Analyst Consensus: Buy

News

DBV Technologies to Participate at Upcoming Investor Conferences

Montrouge, France, August 31, 2021

2 weeks ago - GlobeNewsWire

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

AMF REGULATED INFORMATION Montrouge, France, August 6, 2021

1 month ago - GlobeNewsWire

DBV Technologies to Present at Upcoming Investor Conferences

Montrouge, France, June 2, 2021

3 months ago - GlobeNewsWire

DBV Technologies Announces Filing of its First Form 10-Q for the First Quarter of 2021

Montrouge, France, May 5, 2021

4 months ago - GlobeNewsWire

DBV Technologies Reports Q1 2021 Financial Results

Montrouge, France, May 3, 2021

4 months ago - GlobeNewsWire

DBV Technologies to Participate in Upcoming Investor Conferences

Montrouge, France, April 29, 2021

4 months ago - GlobeNewsWire

DBV Technologies Announces Appointment of Timothy E. Morris to Board of Directors

Montrouge, France, April 2, 2021 DBV Technologies Announces Appointment of Timothy E. Morris to Board of Directors

5 months ago - GlobeNewsWire

Monthly information regarding the total number of voting rights and total number of shares of the Company as of March...

Monthly information regarding the total number of voting rights and

5 months ago - GlobeNewsWire

Monthly information regarding the total number of voting rights and total number of shares of the Company as of Febru...

Monthly information regarding the total number of voting rights and

6 months ago - GlobeNewsWire

Why DBV Technologies Stock Is Rising Today

The company released its latest quarterly update, and investors liked what they saw.

6 months ago - The Motley Fool

DBV Technologies Reports Full-Year 2020 Financial Results and Recent Business Developments

Montrouge, France, March 11, 2021

6 months ago - GlobeNewsWire

DBV Technologies to Participate in the H.C. Wainwright Global Life Sciences Conference

Montrouge, France, March 5, 2021

6 months ago - GlobeNewsWire

DBV Technologies Announces Date Change for Reporting Full Year 2020 Financial Results

Montrouge, France, March 3, 2021

6 months ago - GlobeNewsWire

DBV Technologies to Report Full Year 2020 Financial Results on March 4, 2021

Montrouge, France, March 1, 2020

6 months ago - GlobeNewsWire

DBV Technologies to Participate in Upcoming AAAAI 2021 Congress

Montrouge, France, February 24, 2021

6 months ago - GlobeNewsWire

DBV Technologies Announces Appointment of Michele F. Robertson as Chief Legal Officer

Montrouge, France, February 22, 2021

6 months ago - GlobeNewsWire

DBV Technologies to Participate in SVB Leerink Global Partners Healthcare Conference

Montrouge, France, February 19, 2021

6 months ago - GlobeNewsWire

Monthly information regarding the total number of voting rights and total number of shares of the Company as of Janua...

Monthly information regarding the total number of voting rights and

7 months ago - GlobeNewsWire

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

AMF REGULATED INFORMATION Montrouge, France, January 29, 2021

7 months ago - GlobeNewsWire